Layn(SZ:002166) Zheng Quan Zhi Xing·2025-07-09 16:11Group 1 - The core point of the announcement is that Qin Benjun, the controlling shareholder of Guilin Rhine Biotechnology Co., Ltd., has extended the repurchase of pledged shares to Guohai Securities Co., Ltd. [1] - The total number of shares pledged by Qin Benjun is 10,070,000, which accounts for 37.11% of his holdings and 13.58% of the company's total share capital [1][2] - As of the announcement date, Qin Benjun's pledged shares amount to 27,138,960, representing 23.43% of his total holdings, with 7,668,880 shares (36.59%) being pledged [2] Group 2 - The announcement details that 6,593,440 shares are due for repayment within the next six months, which is 24.30% of the pledged shares and 8.89% of the company's total share capital [2] - A total of 16,663,440 shares are due within the next year, representing 61.40% of the pledged shares and 22.47% of the company's total share capital [2] - The company confirms that Qin Benjun has a good credit status and sufficient funds to repay the financing, with repayment sources being self-raised funds [2]